Literature DB >> 26525886

Primary Headache Disorders: Focus on Migraine.

Anish Bahra1.   

Abstract

Migraine is the most common disabling headache disorder.Most patients with disabling tension-type headache are likely to have migraine and accordingly respond to treatments efficacious in migraine.Individuals are genetically predisposed to experiencing recurrent migraine.Evidence supports migraine to be a primarily neural and not vascular mediated disorder.1-2% of the population have chronic daily headache associated with acute-relief medication overuse; the majority are migraineurs.The presence of acute-relief medication overuse renders preventative medication less adequately efficacious.

Entities:  

Keywords:  aura; disabling tension-type headache; headache; medication overuse headache; migraine; primary headache disorders

Year:  2011        PMID: 26525886      PMCID: PMC4590049          DOI: 10.1177/204946371100500402

Source DB:  PubMed          Journal:  Rev Pain


  72 in total

1.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

2.  Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors.

Authors:  S R Lu; J L Fuh; W T Chen; K D Juang; S J Wang
Journal:  Cephalalgia       Date:  2001-12       Impact factor: 6.292

3.  The headache of SAH responds to sumatriptan.

Authors:  Jay H Rosenberg; Stephen D Silberstein
Journal:  Headache       Date:  2005-05       Impact factor: 5.887

4.  Brain stem activation in spontaneous human migraine attacks.

Authors:  C Weiller; A May; V Limmroth; M Jüptner; H Kaube; R V Schayck; H H Coenen; H C Diener
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

5.  Hemicrania continua with aura.

Authors:  M F P Peres; Hua Chiang Siow; T D Rozen
Journal:  Cephalalgia       Date:  2002-04       Impact factor: 6.292

6.  Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial.

Authors:  R B Lipton; W F Stewart; A M Stone; M J Láinez; J P Sawyer
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

7.  A nosographic analysis of the migraine aura in a general population.

Authors:  M B Russell; J Olesen
Journal:  Brain       Date:  1996-04       Impact factor: 13.501

Review 8.  Early treatment of acute migraine: new evidence of benefits.

Authors:  D Valade
Journal:  Cephalalgia       Date:  2009-12       Impact factor: 6.292

9.  Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Authors:  K Silverman; S M Evans; E C Strain; R R Griffiths
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

10.  Premonitory symptoms in migraine: an electronic diary study.

Authors:  N J Giffin; L Ruggiero; R B Lipton; S D Silberstein; J F Tvedskov; J Olesen; J Altman; P J Goadsby; A Macrae
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

View more
  2 in total

1.  Does atorvastatin have augmentative effects with sodium valproate in prevention of migraine with aura attacks? A triple-blind controlled clinical trial.

Authors:  Reza Ganji; Nastaran Majdinasab; Saeed Hesam; Nazanin Rostami; Mehdi Sayyah; Adeleh Sahebnasagh
Journal:  J Pharm Health Care Sci       Date:  2021-04-01

2.  Phenome-wide analysis highlights putative causal relationships between self-reported migraine and other complex traits.

Authors:  Luis M García-Marín; Adrián I Campos; Nicholas G Martin; Gabriel Cuéllar-Partida; Miguel E Rentería
Journal:  J Headache Pain       Date:  2021-07-08       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.